Liabooks Home|PRISM News
PRISM

#Eli Lilly

Total 4 articles

A smartphone showing a health app next to a modern pill bottle.
EconomyEN
GLP-1 Weight-loss Pills 2026: From Clinical Injections to TikTok-Driven Lifestyle Apps

Discover the future of GLP-1 weight-loss pills in 2026. From oral medication to TikTok influencers and telehealth apps, see how the market is changing.

Novo Nordisk Soars 8% as U.S. Greenlights Oral Wegovy, Unlocking Massive New Market
EconomyEN
Novo Nordisk Soars 8% as U.S. Greenlights Oral Wegovy, Unlocking Massive New Market

Novo Nordisk (NVO) stock jumped 8% following FDA approval for the oral pill version of its weight-loss drug Wegovy. The move is expected to significantly broaden patient access and intensify competition with Eli Lilly.

FDA Approves First-Ever Pill Version of Blockbuster Weight-Loss Drug Wegovy
TechEN
FDA Approves First-Ever Pill Version of Blockbuster Weight-Loss Drug Wegovy

The US FDA has approved the first-ever pill form of Novo Nordisk's blockbuster weight-loss drug, Wegovy. Showing comparable results to the injection in trials, the daily pill is set to launch in January 2026.

FDA Approves Wegovy Pill, Igniting New Front in Billion-Dollar Weight-Loss Drug Race
TechEN
FDA Approves Wegovy Pill, Igniting New Front in Billion-Dollar Weight-Loss Drug Race

The FDA has approved a once-daily pill version of Novo Nordisk's blockbuster weight-loss drug Wegovy, offering a new option versus the weekly shot and escalating competition with Eli Lilly.